Literature DB >> 6352863

The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.

L Kingsford, D W Hill.   

Abstract

The envelope of the bunyavirus La Crosse contains two glycoproteins, G1 (120 000 mol. wt.) and G2 (38 000 mol. wt.). When incubated with trypsin or plasmin, the G1 glycoprotein of virus grown in cell culture was cleaved, leaving two different sized polypeptides in the envelope (67 000 and 95 000 mol. wt.). Chymotrypsin cleaved G1 leaving polypeptides of 70 000 and 100 000 mol. wt. G2, however, was not altered by these enzymes. When used in antibody neutralization studies, these proteolytically modified viruses were neutralized approximately 1 to 2 log10 units in 60 min while control virus was neutralized by over 4 log10 units in 20 min. Because antibody to G1, but not G2, was involved in La Crosse virus neutralization, cleavage of G1 appeared to be directly responsible for these altered kinetics of neutralization. Antibody did bind to the polypeptides remaining associated with the envelope resulting in infectious virus-antibody complexes. This indicated that a critical site in terms of antibody neutralization was removed from G1 by proteolytic enzymes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352863     DOI: 10.1099/0022-1317-64-10-2147

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  Batai and Ngari viruses: M segment reassortment and association with severe febrile disease outbreaks in East Africa.

Authors:  Thomas Briese; Brian Bird; Vishal Kapoor; Stuart T Nichol; W Ian Lipkin
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Cross reactivity of neutralizing antibodies to the encephalitic California Serogroup orthobunyaviruses varies by virus and genetic relatedness.

Authors:  Alyssa B Evans; Karin E Peterson
Journal:  Sci Rep       Date:  2021-08-12       Impact factor: 4.996

3.  Prevalence and protein specificity of human antibodies to Inkoo virus infection.

Authors:  Niina Putkuri; Antti Vaheri; Olli Vapalahti
Journal:  Clin Vaccine Immunol       Date:  2007-10-17

4.  High genetic variability of Schmallenberg virus M-segment leads to efficient immune escape from neutralizing antibodies.

Authors:  Kerstin Wernike; Ilona Reimann; Ashley C Banyard; Franziska Kraatz; S Anna La Rocca; Bernd Hoffmann; Sarah McGowan; Silke Hechinger; Bhudipa Choudhury; Andrea Aebischer; Falko Steinbach; Martin Beer
Journal:  PLoS Pathog       Date:  2021-01-26       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.